Evotec is a small molecule and biologics drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, and venture capitalists. We cover all activities from target-to-clinic to meet the industry’s need for innovation and efficiency. Evotec has established substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications, pain and inflammation, oncology, infectious diseases, respiratory diseases, and fibrosis. Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages.